Alkermes
ALKS
#2795
Rank
โ‚น537.81 B
Marketcap
โ‚น3,227
Share price
-0.60%
Change (1 day)
15.90%
Change (1 year)

Revenue for Alkermes (ALKS)

Revenue in 2025 (TTM): โ‚น129.22 Billion

According to Alkermes's latest financial reports the company's current revenue (TTM ) is โ‚น136.71 Billion. a decrease over the revenue in the year 2024 that were of โ‚น133.62 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alkermes from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น132.49 B-0.85%
2024 โ‚น133.62 B-3.5%
2023 โ‚น138.47 B50.52%
2022 โ‚น92.00 B5.31%
2021 โ‚น87.36 B15%
2020 โ‚น75.96 B-9.02%
2019 โ‚น83.50 B9.13%
2018 โ‚น76.51 B32.65%
2017 โ‚น57.68 B13.83%
2016 โ‚น50.67 B21.36%
2015 โ‚น41.75 B6.47%
2014 โ‚น39.21 B
2012 โ‚น29.70 B80.79%
2011 โ‚น16.43 B110.79%
2010 โ‚น7.79 B-8.53%
2009 โ‚น8.52 B-48.66%
2008 โ‚น16.60 B73.96%
2007 โ‚น9.54 B-5.82%
2006 โ‚น10.13 B65.59%
2005 โ‚น6.11 B104.25%
2004 โ‚น2.99 B86.5%
2003 โ‚น1.60 B-29.59%
2002 โ‚น2.28 B-7.91%
2001 โ‚น2.47 B19.2%
2000 โ‚น2.07 B92.18%
1999 โ‚น1.08 B-44.92%
1998 โ‚น1.96 B78.51%
1997 โ‚น1.09 B67.13%
1996 โ‚น0.65 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.725 T 6,282.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.249 T 3,739.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น5.796 T 4,140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.994 T 3,553.48%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น4.464 T 3,165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.440 T 3,879.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
โ‚น7.56 B-94.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น10.71 B-92.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.598 T 1,069.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel